BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 194192)

  • 1. Why the delay in cancer-protection standards?
    Rose V
    Occup Health Saf; 1977; 46(3):49-50. PubMed ID: 194192
    [No Abstract]   [Full Text] [Related]  

  • 2. Measures for the prevention of occupational cancer.
    Weaver NK
    J Occup Med; 1976 Sep; 18(9):607-10. PubMed ID: 966092
    [No Abstract]   [Full Text] [Related]  

  • 3. Legislation concerning carcinogens at work. The situation in Italy.
    FoĆ  V; D'Angelo V
    Med Lav; 1986; 77(4):393-5. PubMed ID: 3784947
    [No Abstract]   [Full Text] [Related]  

  • 4. Industrial views and concerns with regard to regulatory process.
    Smith CW
    Tex Rep Biol Med; 1978; 37():204-11. PubMed ID: 752981
    [No Abstract]   [Full Text] [Related]  

  • 5. Legislation in Belgium regarding the use of carcinogenic substances.
    Lehoucq A
    Med Lav; 1986; 77(4):370-5. PubMed ID: 3784944
    [No Abstract]   [Full Text] [Related]  

  • 6. The approach used by the Occupational Safety and Health Administration (OSHA) to regulate occupational carcinogens.
    Rowland R
    Med Lav; 1986; 77(4):457-66. PubMed ID: 3784958
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulatory aspects of carcinogenic substances in the Netherlands.
    Balemans AW
    Med Lav; 1986; 77(4):399-401. PubMed ID: 3784948
    [No Abstract]   [Full Text] [Related]  

  • 8. Survey of the regulatory aspects of carcinogenic substances in Spain.
    Ramos ES
    Med Lav; 1986; 77(4):412-7. PubMed ID: 3784951
    [No Abstract]   [Full Text] [Related]  

  • 9. Legal provisions in Portugal regarding the control of carcinogenic substances at work.
    Leandro D
    Med Lav; 1986; 77(4):407-11. PubMed ID: 3784950
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinogenic risk management in the United States.
    Selikoff IJ
    Ann N Y Acad Sci; 1981; 363():283-93. PubMed ID: 6942729
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical agents and occupational cancer.
    Cole P; Merletti F
    J Environ Pathol Toxicol; 1980 Mar; 3(4 Spec No):399-417. PubMed ID: 6993616
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulators and workplace carcinogens.
    Yodaiken RE; Jones E; Spolnicki HG; Deitchman S
    Occup Med; 1987; 2(1):197-206. PubMed ID: 3306975
    [No Abstract]   [Full Text] [Related]  

  • 13. Legislative problems in the control of carcinogens in the United Kingdom.
    Burgess CD
    Med Lav; 1986; 77(4):402-6. PubMed ID: 3784949
    [No Abstract]   [Full Text] [Related]  

  • 14. OSHA announces proposed cancer policy..
    Am Ind Hyg Assoc J; 1977 Apr; 38(4):A24-9. PubMed ID: 868752
    [No Abstract]   [Full Text] [Related]  

  • 15. How do you inform labor, management, and other professionals about toxicity data?
    Sprout WL
    Occup Health Saf; 1978; 47(2):20-1. PubMed ID: 634522
    [No Abstract]   [Full Text] [Related]  

  • 16. Occupational carcinogens: standards issued by the International Labour Organization.
    Parmeggiani L
    Med Lav; 1986; 77(4):449-56. PubMed ID: 3784957
    [No Abstract]   [Full Text] [Related]  

  • 17. A contribution to the discussion on health checks for workers exposed to carcinogenic substances.
    Merler E
    Med Lav; 1986; 77(4):475-9. PubMed ID: 3784960
    [No Abstract]   [Full Text] [Related]  

  • 18. [Primary prevention of cancer. Scientific background and operational strategies. Carcinogens in the general and occupational environment].
    Med Lav; 1998; 89(2):94-5. PubMed ID: 9673096
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection from adverse effects of benzene.
    Tabershaw IR
    Tex Rep Biol Med; 1978; 37():162-9. PubMed ID: 752976
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: the Criteria Document for Coke Oven Emissions.
    Halen RJ
    J Occup Med; 1973 Sep; 15(9):738-9. PubMed ID: 4517275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.